Agios Provides Update on U.S. sNDA for Mitapivat in Thalassemia
Go back to Agios Provides Update on U.S. sNDA for Mitapivat in Thalassemia| AGIOS PHARM (NASDAQ: AGIO) | Delayed: 34.21 +0.53 (1.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $33.68 | 52 Week High | $71.49 | |||
| Open | $33.60 | 52 Week Low | $33.50 | |||
| Day High | $34.34 | P/E | N/A | |||
| Day Low | $33.21 | EPS | $-1.18 | |||
| Volume | 926,954 | |||||
